Johnson & Johnson Innovation (JJI), announced it entered a definitive agreement to join NXT Biomedical Therapeutic Device Incubator (NXT) through a strategic investment facilitated by Johnson & Johnson Innovation – JJDC. Created in September 2018 by Deerfield Management Company, L.P. (Deerfield) and Stanton Rowe, CEO of NXT Biomedical, this next-generation...